Today

Agents

Chat

Arena

Discover

More

App

BeOne Medicines CEO John Oyler reports disposal of shares worth $75.72 million - ONC News | Rallies

BeOne Medicines CEO John Oyler reports disposal of shares worth $75.72 million

ONC•2026-07-17

CEO reports share sales and option exercises

BeOne Medicines CEO John Oyler reported sales totaling 260,359 American Depositary Shares on July 15-16 at prices near USD 310-324.
Oyler also exercised stock options for 283,154 American Depositary Shares on July 15-16 at prices of USD 100.04, USD 119.96, USD 160.40, USD 169.58.
He ended July 16 with 0 American Depositary Shares held directly.
Direct holdings included 5,445,917 ordinary shares following the transactions.

Related News

Bicara Therapeutics Inc <BCAX.O>: BTIG Raises Target Price to $39 From $28

BCAX•2026-08-12

Morning Bid Europe-Hot spots sizzle, CPI looms

SPY•2026-08-12

The Middleby Corporation <MIDD.O>: JP Morgan cuts target price to $141 from $151

Sources

S

BeOne Medicines CEO John Oyler reports disposal of shares worth $75.72 million

Sec

2026-08-12

Silence Therapeutics prices upsized $175 million ADS offering at $13.5 each

SLN•2026-08-12

CytoSorbents posts investor presentation outlining Q2 revenue, cash burn progress toward breakeven

CTSO•2026-08-12